SEC Form 4 · accession 0001686266-17-000015
ReShape Lifesciences Inc. · RSLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott P Youngstrom
Officer — CFO and CCO
Period of report
Oct 6, 2017
Accepted (ET)
Oct 12, 2017 · 6:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001371217
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value per share | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.05 | Oct 6, 2017 | A | 284,120 | A | — | Oct 6, 2027 | Common stock | 284,120 | 284,120 | D |
Explanation of responses
- F1Subject to the continued service of employee, 25% of shares will vest on one-year anniversary of October 6, 2017 and the remaining 75% of shares will vest in as nearly equal amounts as possible on the last day of each of the next 36 months thereafter.